FDA Inspection 1154344 — Vitalant
The FDA completed an inspection of Vitalant on September 24, 2021 in Billings, MT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 24, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Billings, MT (United States)